奥力保克防治蛛网膜下腔出血后脑血管痉挛的临床观察  

Clinical Observation on OLIBOWK in Prevention and Cure Cerebal Vasospasm after Subarachnoid Hemorrhage

作　　者：许美玲[1] 王永贵[1] 

机构地区：[1]哈尔滨医科大学第四临床医学院,黑龙江哈尔滨150001

出　　处：《黑龙江医学》2009年第10期760-761,共2页Heilongjiang Medical Journal

摘　　要：目的探讨奥力保克对蛛网膜下腔出血（SAH）后脑血管痉挛（CVS）的治疗作用。方法将42例蛛网膜下腔出血住院患者随机分成两组,奥力保克组（20例）和对照组（22例）。两组均于发病48 h内接受治疗,对照组用脱水、止血等常规疗法;奥力保克组在常规疗法基础上加用奥力保克5.0 mg,3次/d,口服,共3-4周。结果1个月内,奥力保克组的CVS发生率、死亡率明显低于对照组（P〈0.05）,再出血发生率两组比较无明显差异（P〉0.05）。结论奥力保克防治SAH后CVS疗效确切,并能促进神经功能的尽快恢复,且无增加再出血的危险。Objective To explore the treatment effect of OLIBOWK（Flunayizine Hydrochloride Capsules） in cure cerebal vasospasm （CVS） after subarachnoid hemorrhage （SAH）. Methods 42 cases of SAH patients were divided into two groups randomly, OHBOWK （20 cases） group and control group （22 cases）. All cases were adopted treatment within 48h post onset. The control group was adopted conventional therapy such as dehydration, hemostasis et al. OLIBOWK group was adopted OLIBOWK treatment, 5.0mg, tid po. 3 - 4 weeks except conventional trerapy. Results The CVS incidence rate and death rate in OLIBOWK group was lower than control group obviously （ P 〈 0. 05）. However in rehaemorrhagia rate, there was no significant deviation （ P 〉 0.05）. Conclusion OLIBOWK in prevention and curing CVS after SAH has good curative effect. it can promote the neurofunctional recovery and no rehemorrhagic risk.

关 键 词：奥力保克 蛛网膜下腔出血 脑血管痉挛 

分 类 号：R741[医药卫生—神经病学与精神病学]